Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

2.

Should you take a statin if your cholesterol is normal? Consider this option after determining your personal risk with your doctor.

[No authors listed]

Harv Mens Health Watch. 2012 Nov;17(4):1, 7. No abstract available.

PMID:
23330200
3.

Intensive statin therapy for Indians: Part-I. Benefits.

Enas EA, Pazhoor HC, Kuruvila A, Vijayaraghavan K.

Indian Heart J. 2011 May-Jun;63(3):211-27. Review.

PMID:
22734339
4.

Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?

Fabbri G, Maggioni AP.

Adv Ther. 2009 May;26(5):469-87. doi: 10.1007/s12325-009-0025-6. Epub 2009 May 14. Review.

PMID:
19444394
6.

Statin use prolongs patient survival after renal transplantation.

Ritz E, Wanner C.

J Am Soc Nephrol. 2008 Nov;19(11):2037-40. doi: 10.1681/ASN.2008090925. Epub 2008 Oct 8. No abstract available.

7.

Should statins be prescribed for primary prevention of cardiovascular disease in patients with chronic kidney disease?

Connor A, Tomson C.

BMJ. 2009 Aug 20;339:b2949. doi: 10.1136/bmj.b2949. No abstract available.

PMID:
19696089
10.

Lipid management for the prevention of cardiovascular disease.

Schaefer JR.

Curr Pharm Des. 2011;17(9):852-60. Review.

PMID:
21418030
11.

Cardiovascular disease: Should statin therapy be expanded in patients with CKD?

Jablonski KL, Chonchol M.

Nat Rev Nephrol. 2012 Jul 3;8(8):440-1. doi: 10.1038/nrneph.2012.142. No abstract available.

PMID:
22751508
12.

Statin effects in CKD: is there a "point of no return"?

Wanner C.

Am J Kidney Dis. 2009 May;53(5):723-5. doi: 10.1053/j.ajkd.2009.02.002. No abstract available.

PMID:
19393469
13.

Low-density lipoprotein cholesterol targeting: a continued controversy.

Whayne TF Jr.

Angiology. 2014 Mar;65(3):263-4. doi: 10.1177/0003319713508641. Epub 2013 Oct 31. No abstract available.

PMID:
24176912
14.

Appropriateness of statins in patients aged ≥80 years and comparison to other age groups.

Chokshi NP, Messerli FH, Sutin D, Supariwala AA, Shah NR.

Am J Cardiol. 2012 Nov 15;110(10):1477-81. doi: 10.1016/j.amjcard.2012.06.058. Epub 2012 Aug 14.

PMID:
22901970
15.

Coronary event secondary prevention with statins irrespective of LDL-cholesterol.

Kerst LL, Mauro VF.

Ann Pharmacother. 2004 Jun;38(6):1060-4. Epub 2004 Apr 30. Review.

PMID:
15121997
16.

Statins and the primary prevention of cardiovascular events.

Clearfield M.

Curr Atheroscler Rep. 2006 Sep;8(5):390-6. Review.

PMID:
16901409
17.

Treat-to-target low-density lipoprotein cholesterol: time to debate a too simple and dogmatic paradigm.

Joven J, Martin-Paredero V, Camps J.

Angiology. 2014 Mar;65(3):261-2. doi: 10.1177/0003319713507331. Epub 2013 Oct 24. No abstract available.

PMID:
24163119
18.

Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.

Matsuzaki M, Yokoyama M, Saito Y, Origasa H, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K, Matsuzawa Y; JELIS Investigators.

Circ J. 2009 Jul;73(7):1283-90. Epub 2009 May 8.

19.

Statins for end-stage kidney disease treated with dialysis.

Webster A, Palmer S, Ruospo M, Strippoli GF.

Nephrology (Carlton). 2015 Apr;20(4):302-3. doi: 10.1111/nep.12435. No abstract available.

PMID:
25810229
20.

Statins do not improve cardiovascular outcomes for dialysis patients.

Olyaei A.

Evid Based Med. 2014 Jun;19(3):89. doi: 10.1136/eb-2013-101606. Epub 2013 Dec 12. No abstract available.

PMID:
24336608

Supplemental Content

Support Center